Richard B. Lai Fatt
Keine laufenden Positionen mehr
Profil
Richard B.
Lai Fatt has been Vice President of Corporate Development for Nventa Biopharmaceuticals Corp.
since joining the company in June 2007.
Prior to Nventa Biopharmaceuticals, Dr. Lai Fatt was Vice President of Corporate Development for Kalypsys, Inc. Prior to joining Kalypsys, he was Vice President of Business Development and Strategic Marketing for Isis Pharmaceuticals.
Dr. Lai Fatt held various positions at DuPont Merck Pharmaceuticals, Schering-Plough International, Schering Canada and Lederle Pharmaceuticals.
He received a BS from the University of Miami, Florida and a PhD degree in Biology from McMaster University, Hamilton, Ontario, Canada.
Ehemalige bekannte Positionen von Richard B. Lai Fatt
| Unternehmen | Position | Ende |
|---|---|---|
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Corporate Officer/Principal | - |
Ausbildung von Richard B. Lai Fatt
| University of Miami | Undergraduate Degree |
| McMaster University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
